Probiotics from research to market: the possibilities, risks and challenges.

Bruno Pot, Benoit Foligné, Catherine Daniel

Journal: Current opinion in microbiology 2014;16(3):284-92

PMID: 23866974

Full Text on Elsevier Science View on PubMed

Abstract

Probiotic foods can affect large parts of the population, while therapeutic applications have a less wide scope. While commercialization routes and regulatory requirements differ for both applications, both will need good scientific support. Today, probiotics are mainly used for gastrointestinal applications, their use can easily be extended to skin, oral and vaginal health. While most probiotics currently belong to food-grade species, the future may offer new functional microorganisms in food and pharma. This review discusses the crosstalk between probiotic producers, regulatory people, medical care and healthcare workers, and the scientific community.

Address: Institut Pasteur de Lille, Lactic acid Bacteria & Mucosal Immunity, Center for Infection and Immunity of Lille, 1, rue du Pr Calmette, BP 245, F-59019 Lille, France.

DOI: 10.1016/j.mib.2013.06.008

Link outs

Free resources

Other Literature Sources:

Subscription / membership required

Full Text Sources:

MeSH Terms: Biological Therapy, Diet, Drug Approval, Humans, Probiotics